Zobrazeno 1 - 7
of 7
pro vyhledávání: '"R E G, Schutgens"'
Autor:
J. W. Hoefnagels, K. Fischer, R. A. T. Bos, M. H. E. Driessens, S. L. A. Meijer, R. E. G. Schutgens, L. H. Schrijvers
Publikováno v:
Pilot and Feasibility Studies, Vol 6, Iss 1, Pp 1-11 (2020)
Abstract Introduction Haemophilia is a congenital bleeding disorder mainly affecting males. To prevent bleeding, patients need to perform regular intravenous injections (prophylaxis) throughout life. Non-adherence often occurs. Problems with acceptan
Externí odkaz:
https://doaj.org/article/7e7bdf3324974ceaa0e320ce3ffbca30
Autor:
E D P, van Bergen, M, Monnikhof, F P J G, Lafeber, R E G, Schutgens, S C, Mastbergen, L F D, van Vulpen
Publikováno v:
Blood Reviews. 56:100987
(Non-)selective non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for musculoskeletal related pain. These cheap and easily accessible drugs may be of great value for hemophilia patients in developing countries and countries with a high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c77a070f9ee5f7893ba6f4eb8ef01a01
https://doi.org/10.1016/j.blre.2022.100987
https://doi.org/10.1016/j.blre.2022.100987
Publikováno v:
Hamostaseologie. 33(4)
Patients with haemophilia (PWH) are relatively protected from cardiovascular death. Recent insights have shown that this is not due to less formation of atherosclerosis than in non-haemophilic men, therefore protection from the final occlusive thromb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f98d4c63f6f8122f8c44786b20ac034f
https://pubmed.ncbi.nlm.nih.gov/29589343
https://pubmed.ncbi.nlm.nih.gov/29589343
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 20(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f294825ff09214b29a8a7ae5c4bed6f
https://pubmed.ncbi.nlm.nih.gov/25296569
https://pubmed.ncbi.nlm.nih.gov/25296569
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::16024eee2256ff2208bdbef49677610b
https://pubmed.ncbi.nlm.nih.gov/21323799
https://pubmed.ncbi.nlm.nih.gov/21323799
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(2)
Mild haemophilia A is a rare disease with a relatively mild phenotype. Treatment with factor VIII (FVIII) is indicated after trauma or for surgery only. FVIII infusion may result in the development of inhibiting antibodies against FVIII. This study d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d5a51f9fb667be377242f5053390816
https://pubmed.ncbi.nlm.nih.gov/21851507
https://pubmed.ncbi.nlm.nih.gov/21851507
Autor:
I E M, Den Uijl, E P, Mauser Bunschoten, G, Roosendaal, R E G, Schutgens, D H, Biesma, D E, Grobbee, K, Fischer
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(6)
The classification of haemophilia originates from 1950s and has been adopted unchallengedly by the ISTH in 2001. The aim of this study was: does the current classification compare onset of bleeding and age at first treatment, as well as annual joint
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a774d63c31d5cbb297961deb3879b2ed
https://pubmed.ncbi.nlm.nih.gov/21545376
https://pubmed.ncbi.nlm.nih.gov/21545376